FORA · Forian Inc.
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| $30.05M | $30.26M | $20.15M | $21.22M | $16.42M | $16.88M | $544.87K | |
| $15.87M | $14.16M | $7.33M | $5.48M | $5.05M | $4.72M | $38.29K | |
| — | — | — | — | — | — | $506.58K | |
| — | — | — | — | — | — | 92.97% | |
| $3.27M | $2.92M | $1.44M | $1.41M | $4.01M | $8.98M | $2.51M | |
| $6.13M | $6.03M | $4.33M | $4.96M | $3.95M | $4.14M | $573.85K | |
| $8.58M | $9.41M | $12.54M | $12.6M | $16.88M | $23.46M | $1.53M | |
| — | — | — | — | — | — | $2.98M | |
| $192.39K | $190.5K | $33.96K | — | $2.28M | $1.88M | $0 | |
| $208.51K | $207.72K | $63.39K | $74.44K | $65.55K | $1.99M | $8555 | |
| — | — | — | — | — | — | $5.49M | |
| $35.91M | $34.02M | $27.14M | $26.15M | $35.37M | $44.5M | $5.53M | |
| -$5.86M | -$3.76M | -$6.99M | -$4.93M | -$18.95M | -$27.62M | -$4.98M | |
| — | -12.44% | -34.67% | -23.25% | -115.44% | -163.61% | -914.67% | |
| -$5.65M | -$3.56M | -$6.92M | -$4.86M | -$18.89M | -$25.63M | -$4.98M | |
| $89.67K | $142.35K | $708.93K | $834.79K | $846.1K | $322.38K | $0 | |
| $997.56K | $1.12M | $3.28M | $7.41M | -$215.2K | $1.09M | $3574 | |
| -$4.86M | -$2.65M | -$3.7M | $2.48M | -$19.17M | -$26.53M | -$4.98M | |
| $250.53K | $227.97K | $66.58K | $85.74K | $23.98K | $22.51K | $0 | |
| -$5.11M | -$2.87M | -$3.77M | $11.77M | -$25.97M | -$26.55M | -$4.98M | |
| — | -9.5% | -18.71% | 55.47% | -158.19% | -157.3% | -914.01% | |
| — | — | -$3.77M | $2.4M | -$19.19M | — | — | |
| -$5.11M | -$2.87M | -$3.77M | — | — | — | — | |
| USD/shares | — | -$0.09 | -$0.12 | $0.36 | -$0.81 | -$0.90 | -$0.38 |
| USD/shares | — | -$0.09 | -$0.12 | $0.36 | -$0.81 | -$0.90 | -$0.38 |
| shares | — | 31.11M | 31.07M | 32.03M | 32.03M | 29.53M | 13.19M |
| shares | — | 31.11M | 31.07M | 32.23M | 32.03M | 29.53M | 13.19M |
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2024: $3.74M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 26 similar-size Health Information Services companies (of 53 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Health Sciences Revenues | $22,963,413 | $19,052,937 | — | — | — |
| Financial Services Revenues | $7,293,506 | $1,100,326 | — | — | — |
| Other | — | — | $274,256 | $804,940 | $0 |
| Health Care | — | — | $16,418,142 | $7,138,907 | $544,871 |
| Product And Service Other | — | — | $274,256 | $804,940 | $0 |
| Service | — | — | $1,545,656 | $1,122,528 | $0 |
| Software Development | — | — | $9,767,803 | $7,813,340 | $0 |
| Technology Service | — | — | $26,185,945 | $14,952,247 | $544,871 |